profit from every ₹100 of sales.
₹0₹100
Poly Medicure
₹1,681.20-0.70% today
-9.0% in 1 year
1-year low ₹1,191.101-year high ₹1,869.40
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2023 to 2026.
0%20% a year
You pay ₹51.44 for every ₹1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Poly Medicure sold, what it kept, and what it did with the cash.
Sales went from ₹11.1 billion in 2023 to ₹18.8 billion in 2026, with ₹3.31 billion of profit last year.
SalesProfit
Poly Medicure vs. similar companies
Poly Medicure grows the fastest of these 5 and is priced in the middle for its profits.
| Company | Profit from ₹100 of sales | Sales growth a year | Price per ₹1 of profit |
|---|---|---|---|
| Poly Medicure | 51.4× · Expensive | ||
 Intuitive Surgical | 53.8× · Expensive | ||
 EssilorLuxottica Société anonyme | 36.1× · Expensive | ||
 Becton, Dickinson and | 35.4× · Expensive | ||
 Medline | 44.8× · Expensive |
AI analysis
An AI analyst reads Poly Medicure's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of INR | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| 11,087 | 13,657 | 16,698 | 18,753 | |
| 5,993 | 7,614 | 11,144 | 12,784 | |
| 2,179 | 3,027 | 3,702 | 3,268 | |
| 3,032 | 4,189 | 5,477 | 5,613 | |
| 1,793 | 2,583 | 3,386 | 3,313 | |
| 18.67 | 26.90 | 34.11 | – | |
| 54.1% | 55.8% | 66.7% | 68.2% | |
| 19.6% | 22.2% | 22.2% | 17.4% | |
| 16.2% | 18.9% | 20.3% | 17.7% |
Balance sheet
| In millions of INR | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Total assets | 15,772 | 18,587 | 31,925 | 39,186 |
| Cash | 71 | 121 | 87 | 512 |
| Total debt | 1,490 | 1,739 | 1,802 | 3,536 |
| Total liabilities | 3,356 | 3,886 | 4,268 | 7,693 |
| 12,416 | 14,701 | 27,657 | 31,062 | |
| 96 | 96 | 99 | – | |
| 13.3% | 16.2% | 11.8% | 9.7% | |
| 14.4% | 17.6% | 12.2% | 10.7% |
Cash flow
| In millions of INR | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| 1,911 | 2,661 | 2,330 | 2,464 | |
| 2,393 | 2,770 | 3,310 | 3,084 | |
| -482 | -109 | -980 | -620 | |
| Dividends paid | 240 | 287 | 303 | 354 |
| – | – | – | – | |
| – | – | – | – |
Valuation
- 51.4×
- –
- –
- 4.8×
- 9.1×
- –
- 30.9×
- -0.4%
- 1.9%
- 0.2%
Profitability
- 68.2%
- 17.4%
- 17.7%
- –
- 9.7%
- 12.7%
- –
- –
- –
- –
Growth
- +19.1%
- –
- –
- –
- +1.1%
Financial health
- 0.5×
- 0.11
- –
- 24.4×
- 3.37
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 31%of 952
Top 28%of 884
Bottom 21%of 601
Top 28%of 886
Bottom 36%of 987
0.2%of the share price, paid each year
On $1,000 invested$2a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
10.7% of its profit
Room to growStretchedMore than it earnsNews
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
54No pass
Benjamin Graham
45No pass
Philip Fisher
52No pass
Peter Lynch
86Pass
Joel Greenblatt
7No pass
Charlie Munger
44No pass
Terry Smith
36No pass
Questions about Poly Medicure
Is Poly Medicure a good stock to buy?
A solid business, but the price is high. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Poly Medicure AI analysis
What does Poly Medicure do?
Poly Medicure Limited engages in the manufacture and sale of medical devices in India and internationally. It is in Medical Instruments & Supplies, based in New Delhi, India.
Does Poly Medicure pay a dividend?
Yes. At today's price the dividend is 0.2% a year, about 11% of its yearly profit. In 2026 it paid out ₹354 million in dividends.
Is Poly Medicure stock halal?
Yes. Poly Medicure passes our halal screen: its business is permitted and its debt is 2% of its market value, under the 30% limit. How we check
How has Poly Medicure stock done over the past year?
Down 9.0% over the past twelve months, to ₹1,681.20. It traded between ₹1,191.10 and ₹1,869.40 and is 10.1% below its high.
Who are Poly Medicure's competitors?
The largest listed companies in the same industry are Intuitive Surgical, EssilorLuxottica Société anonyme, Becton, Dickinson and and Medline. The peers table on this page compares their profit, growth and price with Poly Medicure's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.